Conference Overview
Join us for the CCHFVaccine Final Symposium, where leading scientists will share insights and exchange knowledge on the latest findings related to the Crimean-Congo-Hemorrhagic Fever (CCHF). This conference marks the culmination of years of research and development on a groundbreaking vaccine journey.
Topics of Discussion
- Virus and Immune Response: updates on the latest scientific findings about CCHF virus and the body's immune response
- Vaccine Development journey: follow the progress from initial vaccine candidates to the DNA vaccine Phase 1 candidate (evaluating safety), which received ethical approval to start in Sweden in September 2024.
- Regulatory and Strategic Challenges: Discuss the potenital hurdles for vaccine uptake and explore vaccination challenges in different parts of the world
- HE-funded project CCHFVACIM: receive information about the newly-funded Horizon Europe project and benefit from networking opportunities
For more information download the Program: Here
Participation Details
- Physical Attendance: Limited to 60 participants, Brussels, the Residence Palace
- Online Participation: Open to all. Participation link will be provided, after registration
Register Now
Reserve your spot and be part of this pivotal discussion on advancing CCHF vaccine research : REGISTER